JOSÉ LUIS
PEDRAZ MUÑOZ
Universitat de Barcelona
Barcelona, EspañaPublications en collaboration avec des chercheurs de Universitat de Barcelona (13)
2020
-
iPSC-Derived Intestinal Organoids from Cystic Fibrosis Patients Acquire CFTR Activity upon TALEN-Mediated Repair of the p.F508del Mutation
Molecular Therapy - Methods and Clinical Development, Vol. 17, pp. 858-870
2019
-
Enzymatic crosslinked gelatin 3D scaffolds for bone tissue engineering
International Journal of Pharmaceutics, Vol. 562, pp. 151-161
2017
-
Benznidazole nanoformulates: A chance to improve therapeutics for Chagas disease
American Journal of Tropical Medicine and Hygiene, Vol. 97, Núm. 5, pp. 1469-1476
-
Determination of the spatiotemporal dependence of Pseudomonas aeruginosa biofilm viability after treatment with NLC-colistin
International Journal of Nanomedicine, Vol. 12, pp. 4409-4413
2016
-
Killing effect of nanoencapsulated colistin sulfate on Pseudomonas aeruginosa from cystic fibrosis patients
Journal of Cystic Fibrosis, Vol. 15, Núm. 5, pp. 611-618
-
Pulmonary delivery of tobramycin-loaded nanostructured lipid carriers for Pseudomonas aeruginosa infections associated with cystic fibrosis
International Journal of Pharmaceutics, Vol. 498, Núm. 1-2, pp. 263-273
-
Stability study of sodium colistimethate-loaded lipid nanoparticles
Journal of Microencapsulation, Vol. 33, Núm. 7, pp. 636-645
2015
-
Antibióticos nanoencapsulados en el combate contra las infecciones respiratorias por "Pseudomonas aeruginosa"
Avances en microbiología
-
Development of surface modified biodegradable polymeric nanoparticles to deliver GSE24.2 peptide to cells: A promising approach for the treatment of defective telomerase disorders
European Journal of Pharmaceutics and Biopharmaceutics, Vol. 91, pp. 91-102
2014
-
Sodium colistimethate loaded lipid nanocarriers for the treatment of Pseudomonas aeruginosa infections associated with cystic fibrosis
International Journal of Pharmaceutics, Vol. 477, Núm. 1-2, pp. 485-494
2009
-
A proline-rich peptide improves cell transfection of solid lipid nanoparticle-based non-viral vectors
Journal of Controlled Release, Vol. 133, Núm. 1, pp. 52-59
2005
-
Long-term expression of erythropoietin from myoblasts immobilized in biocompatible and neovascularized microcapsules
Molecular Therapy, Vol. 12, Núm. 2, pp. 283-289
1985
-
Pharmacokinetics of amoxapine and its active metabolites
International Journal of Clinical Pharmacology, Therapy and Tox., Vol. 23, pp. 180-185